Dallah board recommends 2.5% dividend for H2 2020
Dallah Healthcare Co.’s (Dallah) board of directors recommended a 2.5% cash dividend, at SAR 0.25 per share, for the second half of the fiscal year 2020, the company said in a bourse filing.
|
Dividend Details (H2 2020) |
|
|
Current Capital |
SAR 900 mln |
|
Number of shares |
90 mln |
|
Dividend |
SAR 22.5 mln |
|
Percentage of capital |
2.5% (SAR 0.25 per share) |
|
Record date |
March 28, 2021 (Including registered shareholders at the Securities Depository Center (Edaa) at the end of second trading day following due date) |
|
Payment date |
April 11, 2021 |
|
Total Dividend for 2020 |
|
|
Total dividend |
SAR 67.5 mln |
|
Percentage of capital |
7.5% (SAR 0.75 per share) |
Dividend History (SAR/share) Corporate Actions
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 23/03/2021 | 28/03/2021 | 11/04/2021 | 22.50 | 0.25 | |
| 15/12/2020 | 24/12/2020 | 28/12/2020 | 45.00 | 0.50 | |
| 27/02/2020 | 22/03/2020 | 05/04/2020 | 52.50 | 0.58 | |
| 12/11/2019 | 28/11/2019 | 05/12/2019 | 37.50 | 0.42 | |
| 13/12/2018 | 20/12/2018 | 06/01/2019 | 88.50 | 0.98 | |
| 13/12/2017 | 22/05/2018 | 11/06/2018 | 147.50 | 1.64 | |
| 23/02/2017 | 26/04/2017 | 08/05/2017 | 118.00 | 1.31 | |
| 21/01/2016 | 02/05/2016 | 31/05/2016 | 88.50 | 0.98 | |
| 19/02/2015 | 29/04/2015 | 08/06/2015 | 47.20 | 0.52 | |
| 19/02/2014 | 30/04/2014 | 06/06/2014 | 70.80 | 0.79 |
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any
Dividend History
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | 2.73 | 66.20 | 4.13 % |
| Last 5 Financial years | 5.68 | 47.46 | 11.98 % |
| Last 10 Financial years | N/A | N/A | N/A |
Based on the beginning of the period (January 1 of the base year)
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Most Read
- Avalon Pharma renews SAR 50M credit facilities with Alinma Bank
- Al Rashid Industrial to distribute 6% cash dividend for H1 2026
- Which stocks, REITs go ex-dividend today
- Alkhaleej Training targets SAR 550M topline in 2026
- Sector pressures not reflective of fundamental weakness; demand expected to improve in Q3: Budget Saudi CEO
Valuation Data (Latest Share Price)
| P/E (TTM) | 23.21 |
| Recurring P/E (TTM) | 23.32 |
| P/BV | 2.49 |
| Dividend Yield | 1.59 % |
| Market Cap. (M) | 10,279.40 |
| Return on Average Assets | 4.83 % |
| Return on Average Equity | 10.72 % |
Call Request
Comments Analysis: